Physician

Rashmi Chandekar Shah, M.D.

According to 2025 Medicare claims, Rashmi Shah, M.D. (NPI: 1053501742) practices rheumatology in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Washington, OR. This provider's primary affiliated billing organization is NORTHWEST RHEUMATOLOGY ASSOCIATES, PC (NPI: 1043260920; TIN: 931100743) and primary practice location at 97225-6691.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 388 traditional Medicare patients, billed 65,451 HCPCS/CPT codes, and received $922,451 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 3,262 prescription claims across 496 beneficiaries totaling $2,493,893 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 2 records totaling $242. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $11,939 to $922,451. Similarly, Part D prescription costs have moved sharply higher in recent years, from $189,732 to $2,493,893. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	37	81	$11,939
2017	218	11,351	$419,152
2018	238	22,943	$642,658
2019	285	39,982	$740,659
2020	382	41,919	$817,626
2021	470	70,226	$1,242,484
2022	433	96,897	$1,285,425
2023	392	77,419	$1,006,604
2024	388	65,451	$922,451

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	38	259	$189,732
2016	60	244	$179,418
2017	261	1,449	$522,999
2018	352	2,542	$1,094,536
2019	384	2,958	$1,324,036
2020	444	2,842	$1,341,755
2021	473	3,007	$1,479,355
2022	471	2,894	$2,074,875
2023	474	3,025	$2,278,183
2024	496	3,262	$2,493,893

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	75	121	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	206	351	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	80	84	$64
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	82	199	$46
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	180	294	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	44	1,742	$557,404
Humira(Cf) Pen	Adalimumab	46	1,288	$325,662
Humira Pen	Adalimumab	41	1,232	$318,722
Xeljanz Xr	Tofacitinib Citrate	42	1,260	$271,631
Orencia	Abatacept	25	700	$152,800

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$242	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rashmi Chandekar Shah, M.D.?

Tedicare shows public-source Medicare data for Rashmi Chandekar Shah, M.D. (NPI 1053501742), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rashmi Chandekar Shah, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rashmi Chandekar Shah, M.D.?

Rashmi Chandekar Shah, M.D. is linked to NORTHWEST RHEUMATOLOGY ASSOCIATES, PC (billing NPI 1043260920) in the available physician profile data.

Does Rashmi Chandekar Shah, M.D. have Open Payments data?

Rashmi Chandekar Shah, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.